BofA analyst Adam Ron downgraded Oscar Health (OSCR) to Underperform from Neutral with a price target of $13.50, down from $21.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter